Surveillance of drug-related morbidity and mortality

Room 5A
In programme
Wednesday, 23 October, 2024 - 15:00 to 16:30
View presentations

About

This session explores surveillance methods, trends, and critical factors contributing to drug-related morbidity and mortality.

Chair

Nielsen
Suzanne
Professor and Deputy Director
Monash Addiction Research Centre
Placeholder Image
Handanagić
Senad
Head of sector, Trends and analysis, Public health unit
EUDA
 Portugal

Type

Oral presentation session

Tracks

Hepatitis C, other infectious diseases, and drug-related harms

Keywords

Europe
Quantitative methods
Policy
Health inequalities
Treatment
Opiates
Overdose
Prescription drugs
Comorbidity
Youth/children
Public health
Toxicology and forensic analysis
Risky behaviours
Harm reduction

Presentations

Wednesday, 23 October

15:00

Oral presentation

Acute drug-toxicity presentations involving crack cocaine to Euro-DEN Plus sentinel hospitals in Europe from 2014-2022

15:00 to 16:30
Room 5A
Isabelle Giraudon

Oral presentation

Drug poisoning deaths of under 30-year-olds – Key issues in the cause of death investigation documents

15:00 to 16:30
Room 5A
Sanna Rönkä

Oral presentation

Mortality among first-time opioid agonist therapy patients in Austria, 2002-2021: A national retrospective cohort study

15:00 to 16:30
Room 5A
Tanja Schwarz

Oral presentation

Mothers receiving substance use treatment involved in care proceedings: A record linkage cohort study

15:00 to 16:30
Room 5A
Martha Canfield
View the programme